nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluvastatin—UGT2B7—urinary bladder cancer	0.493	1	CbGaD
Fluvastatin—UGT2B7—Epirubicin—urinary bladder cancer	0.0509	0.175	CbGbCtD
Fluvastatin—CYP2B6—Thiotepa—urinary bladder cancer	0.0489	0.168	CbGbCtD
Fluvastatin—UGT1A1—Etoposide—urinary bladder cancer	0.0343	0.118	CbGbCtD
Fluvastatin—SLCO1B3—Methotrexate—urinary bladder cancer	0.0269	0.0926	CbGbCtD
Fluvastatin—SLCO1B1—Methotrexate—urinary bladder cancer	0.0157	0.054	CbGbCtD
Fluvastatin—CYP3A4—Thiotepa—urinary bladder cancer	0.015	0.0517	CbGbCtD
Fluvastatin—CYP2B6—Cisplatin—urinary bladder cancer	0.0135	0.0464	CbGbCtD
Fluvastatin—CYP2C8—Fluorouracil—urinary bladder cancer	0.012	0.0414	CbGbCtD
Fluvastatin—CYP3A5—Etoposide—urinary bladder cancer	0.0104	0.0359	CbGbCtD
Fluvastatin—CYP2C8—Etoposide—urinary bladder cancer	0.01	0.0346	CbGbCtD
Fluvastatin—CYP1A2—Fluorouracil—urinary bladder cancer	0.00931	0.0321	CbGbCtD
Fluvastatin—CYP2B6—Doxorubicin—urinary bladder cancer	0.00904	0.0311	CbGbCtD
Fluvastatin—CYP2C9—Fluorouracil—urinary bladder cancer	0.00839	0.0289	CbGbCtD
Fluvastatin—CYP1A2—Etoposide—urinary bladder cancer	0.00777	0.0268	CbGbCtD
Fluvastatin—CYP2C9—Cisplatin—urinary bladder cancer	0.00713	0.0245	CbGbCtD
Fluvastatin—CYP2D6—Doxorubicin—urinary bladder cancer	0.00437	0.015	CbGbCtD
Fluvastatin—CYP3A4—Etoposide—urinary bladder cancer	0.00407	0.014	CbGbCtD
Fluvastatin—UGT1A1—urine—urinary bladder cancer	0.00376	0.0965	CbGeAlD
Fluvastatin—CYP3A4—Doxorubicin—urinary bladder cancer	0.00278	0.00956	CbGbCtD
Fluvastatin—Pitavastatin—UGT2B7—urinary bladder cancer	0.00223	0.554	CrCbGaD
Fluvastatin—CYP2C19—urine—urinary bladder cancer	0.00204	0.0523	CbGeAlD
Fluvastatin—Atorvastatin—UGT2B7—urinary bladder cancer	0.0018	0.446	CrCbGaD
Fluvastatin—CYP1A2—urine—urinary bladder cancer	0.00166	0.0427	CbGeAlD
Fluvastatin—UGT2B7—prostate gland—urinary bladder cancer	0.00159	0.0407	CbGeAlD
Fluvastatin—CYP2C9—urine—urinary bladder cancer	0.00158	0.0406	CbGeAlD
Fluvastatin—UGT1A1—prostate gland—urinary bladder cancer	0.00135	0.0346	CbGeAlD
Fluvastatin—CYP3A4—urine—urinary bladder cancer	0.0012	0.0309	CbGeAlD
Fluvastatin—CYP2D6—urine—urinary bladder cancer	0.00119	0.0304	CbGeAlD
Fluvastatin—HMGCR—prostate gland—urinary bladder cancer	0.00117	0.0301	CbGeAlD
Fluvastatin—UGT2B7—renal system—urinary bladder cancer	0.00108	0.0278	CbGeAlD
Fluvastatin—SLCO2B1—prostate gland—urinary bladder cancer	0.000993	0.0255	CbGeAlD
Fluvastatin—HMGCR—seminal vesicle—urinary bladder cancer	0.000992	0.0255	CbGeAlD
Fluvastatin—SLCO1B3—vagina—urinary bladder cancer	0.000959	0.0246	CbGeAlD
Fluvastatin—UGT1A1—renal system—urinary bladder cancer	0.00092	0.0236	CbGeAlD
Fluvastatin—SLC15A1—epithelium—urinary bladder cancer	0.000892	0.0229	CbGeAlD
Fluvastatin—UGT2B7—female reproductive system—urinary bladder cancer	0.000867	0.0222	CbGeAlD
Fluvastatin—HMGCR—epithelium—urinary bladder cancer	0.000862	0.0221	CbGeAlD
Fluvastatin—HMGCR—smooth muscle tissue—urinary bladder cancer	0.00083	0.0213	CbGeAlD
Fluvastatin—SLC15A1—renal system—urinary bladder cancer	0.000827	0.0212	CbGeAlD
Fluvastatin—HMGCR—renal system—urinary bladder cancer	0.000799	0.0205	CbGeAlD
Fluvastatin—HMGCR—urethra—urinary bladder cancer	0.000785	0.0201	CbGeAlD
Fluvastatin—SLCO1B1—renal system—urinary bladder cancer	0.000766	0.0196	CbGeAlD
Fluvastatin—SLCO2B1—renal system—urinary bladder cancer	0.000677	0.0174	CbGeAlD
Fluvastatin—HMGCR—female reproductive system—urinary bladder cancer	0.00064	0.0164	CbGeAlD
Fluvastatin—SLCO1B1—female reproductive system—urinary bladder cancer	0.000613	0.0157	CbGeAlD
Fluvastatin—SLC15A1—vagina—urinary bladder cancer	0.000599	0.0154	CbGeAlD
Fluvastatin—HMGCR—vagina—urinary bladder cancer	0.000579	0.0149	CbGeAlD
Fluvastatin—CYP3A5—prostate gland—urinary bladder cancer	0.000576	0.0148	CbGeAlD
Fluvastatin—SLCO2B1—female reproductive system—urinary bladder cancer	0.000542	0.0139	CbGeAlD
Fluvastatin—CYP2C8—renal system—urinary bladder cancer	0.000435	0.0112	CbGeAlD
Fluvastatin—CYP1A1—epithelium—urinary bladder cancer	0.000433	0.0111	CbGeAlD
Fluvastatin—CYP1A2—renal system—urinary bladder cancer	0.000407	0.0105	CbGeAlD
Fluvastatin—CYP1A1—renal system—urinary bladder cancer	0.000402	0.0103	CbGeAlD
Fluvastatin—CYP1A1—urethra—urinary bladder cancer	0.000395	0.0101	CbGeAlD
Fluvastatin—CYP3A5—renal system—urinary bladder cancer	0.000393	0.0101	CbGeAlD
Fluvastatin—CYP2B6—renal system—urinary bladder cancer	0.00039	0.01	CbGeAlD
Fluvastatin—HMGCR—lymph node—urinary bladder cancer	0.000374	0.00961	CbGeAlD
Fluvastatin—CYP2C19—vagina—urinary bladder cancer	0.000361	0.00927	CbGeAlD
Fluvastatin—CYP2C8—female reproductive system—urinary bladder cancer	0.000349	0.00895	CbGeAlD
Fluvastatin—CYP1A1—female reproductive system—urinary bladder cancer	0.000322	0.00826	CbGeAlD
Fluvastatin—SLCO2B1—lymph node—urinary bladder cancer	0.000317	0.00814	CbGeAlD
Fluvastatin—CYP2C8—vagina—urinary bladder cancer	0.000315	0.00809	CbGeAlD
Fluvastatin—CYP2B6—female reproductive system—urinary bladder cancer	0.000313	0.00803	CbGeAlD
Fluvastatin—CYP2C9—female reproductive system—urinary bladder cancer	0.00031	0.00795	CbGeAlD
Fluvastatin—CYP3A4—renal system—urinary bladder cancer	0.000295	0.00757	CbGeAlD
Fluvastatin—CYP1A1—vagina—urinary bladder cancer	0.000291	0.00747	CbGeAlD
Fluvastatin—CYP2D6—renal system—urinary bladder cancer	0.00029	0.00745	CbGeAlD
Fluvastatin—CYP3A5—vagina—urinary bladder cancer	0.000285	0.0073	CbGeAlD
Fluvastatin—CYP2B6—vagina—urinary bladder cancer	0.000283	0.00726	CbGeAlD
Fluvastatin—CYP3A4—female reproductive system—urinary bladder cancer	0.000236	0.00606	CbGeAlD
Fluvastatin—CYP2D6—female reproductive system—urinary bladder cancer	0.000232	0.00596	CbGeAlD
Fluvastatin—CYP1A1—lymph node—urinary bladder cancer	0.000188	0.00483	CbGeAlD
Fluvastatin—Constipation—Etoposide—urinary bladder cancer	9.17e-05	0.001	CcSEcCtD
Fluvastatin—Conjunctivitis—Epirubicin—urinary bladder cancer	9.17e-05	0.000999	CcSEcCtD
Fluvastatin—Urinary tract infection—Epirubicin—urinary bladder cancer	9.17e-05	0.000999	CcSEcCtD
Fluvastatin—Hypersensitivity—Fluorouracil—urinary bladder cancer	9.1e-05	0.000992	CcSEcCtD
Fluvastatin—Upper respiratory tract infection—Doxorubicin—urinary bladder cancer	9.09e-05	0.000991	CcSEcCtD
Fluvastatin—Hepatitis—Methotrexate—urinary bladder cancer	9.05e-05	0.000986	CcSEcCtD
Fluvastatin—Sweating—Epirubicin—urinary bladder cancer	9.04e-05	0.000985	CcSEcCtD
Fluvastatin—Asthenia—Gemcitabine—urinary bladder cancer	9.01e-05	0.000982	CcSEcCtD
Fluvastatin—Pharyngitis—Methotrexate—urinary bladder cancer	8.98e-05	0.000978	CcSEcCtD
Fluvastatin—Photosensitivity reaction—Doxorubicin—urinary bladder cancer	8.93e-05	0.000973	CcSEcCtD
Fluvastatin—Hepatobiliary disease—Epirubicin—urinary bladder cancer	8.92e-05	0.000972	CcSEcCtD
Fluvastatin—Pruritus—Gemcitabine—urinary bladder cancer	8.89e-05	0.000969	CcSEcCtD
Fluvastatin—Nausea—Thiotepa—urinary bladder cancer	8.87e-05	0.000967	CcSEcCtD
Fluvastatin—Sinusitis—Epirubicin—urinary bladder cancer	8.85e-05	0.000964	CcSEcCtD
Fluvastatin—Feeling abnormal—Etoposide—urinary bladder cancer	8.84e-05	0.000964	CcSEcCtD
Fluvastatin—Gastrointestinal pain—Etoposide—urinary bladder cancer	8.77e-05	0.000956	CcSEcCtD
Fluvastatin—Pruritus—Fluorouracil—urinary bladder cancer	8.74e-05	0.000953	CcSEcCtD
Fluvastatin—Infestation NOS—Doxorubicin—urinary bladder cancer	8.73e-05	0.000951	CcSEcCtD
Fluvastatin—Infestation—Doxorubicin—urinary bladder cancer	8.73e-05	0.000951	CcSEcCtD
Fluvastatin—Visual impairment—Methotrexate—urinary bladder cancer	8.72e-05	0.00095	CcSEcCtD
Fluvastatin—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	8.65e-05	0.000943	CcSEcCtD
Fluvastatin—Hypersensitivity—Cisplatin—urinary bladder cancer	8.63e-05	0.00094	CcSEcCtD
Fluvastatin—Diarrhoea—Gemcitabine—urinary bladder cancer	8.6e-05	0.000937	CcSEcCtD
Fluvastatin—Erythema multiforme—Methotrexate—urinary bladder cancer	8.55e-05	0.000932	CcSEcCtD
Fluvastatin—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	8.55e-05	0.000932	CcSEcCtD
Fluvastatin—Urticaria—Etoposide—urinary bladder cancer	8.52e-05	0.000929	CcSEcCtD
Fluvastatin—Rhinitis—Epirubicin—urinary bladder cancer	8.49e-05	0.000925	CcSEcCtD
Fluvastatin—Abdominal pain—Etoposide—urinary bladder cancer	8.48e-05	0.000924	CcSEcCtD
Fluvastatin—Body temperature increased—Etoposide—urinary bladder cancer	8.48e-05	0.000924	CcSEcCtD
Fluvastatin—Conjunctivitis—Doxorubicin—urinary bladder cancer	8.48e-05	0.000924	CcSEcCtD
Fluvastatin—Urinary tract infection—Doxorubicin—urinary bladder cancer	8.48e-05	0.000924	CcSEcCtD
Fluvastatin—Hepatitis—Epirubicin—urinary bladder cancer	8.47e-05	0.000923	CcSEcCtD
Fluvastatin—Diarrhoea—Fluorouracil—urinary bladder cancer	8.45e-05	0.000921	CcSEcCtD
Fluvastatin—Hypoaesthesia—Epirubicin—urinary bladder cancer	8.42e-05	0.000918	CcSEcCtD
Fluvastatin—Asthenia—Cisplatin—urinary bladder cancer	8.4e-05	0.000916	CcSEcCtD
Fluvastatin—Pharyngitis—Epirubicin—urinary bladder cancer	8.4e-05	0.000916	CcSEcCtD
Fluvastatin—Cardiac disorder—Methotrexate—urinary bladder cancer	8.4e-05	0.000915	CcSEcCtD
Fluvastatin—Sweating—Doxorubicin—urinary bladder cancer	8.36e-05	0.000912	CcSEcCtD
Fluvastatin—Oedema peripheral—Epirubicin—urinary bladder cancer	8.34e-05	0.000909	CcSEcCtD
Fluvastatin—Connective tissue disorder—Epirubicin—urinary bladder cancer	8.32e-05	0.000907	CcSEcCtD
Fluvastatin—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	8.25e-05	0.000899	CcSEcCtD
Fluvastatin—Angiopathy—Methotrexate—urinary bladder cancer	8.21e-05	0.000894	CcSEcCtD
Fluvastatin—Sinusitis—Doxorubicin—urinary bladder cancer	8.19e-05	0.000892	CcSEcCtD
Fluvastatin—Immune system disorder—Methotrexate—urinary bladder cancer	8.17e-05	0.00089	CcSEcCtD
Fluvastatin—Dizziness—Fluorouracil—urinary bladder cancer	8.17e-05	0.00089	CcSEcCtD
Fluvastatin—Visual impairment—Epirubicin—urinary bladder cancer	8.16e-05	0.000889	CcSEcCtD
Fluvastatin—Chills—Methotrexate—urinary bladder cancer	8.12e-05	0.000885	CcSEcCtD
Fluvastatin—Diarrhoea—Cisplatin—urinary bladder cancer	8.01e-05	0.000873	CcSEcCtD
Fluvastatin—Erythema multiforme—Epirubicin—urinary bladder cancer	8e-05	0.000872	CcSEcCtD
Fluvastatin—Alopecia—Methotrexate—urinary bladder cancer	7.99e-05	0.000871	CcSEcCtD
Fluvastatin—Vomiting—Gemcitabine—urinary bladder cancer	7.99e-05	0.000871	CcSEcCtD
Fluvastatin—Mental disorder—Methotrexate—urinary bladder cancer	7.92e-05	0.000864	CcSEcCtD
Fluvastatin—Rash—Gemcitabine—urinary bladder cancer	7.92e-05	0.000863	CcSEcCtD
Fluvastatin—Dermatitis—Gemcitabine—urinary bladder cancer	7.91e-05	0.000863	CcSEcCtD
Fluvastatin—Hypersensitivity—Etoposide—urinary bladder cancer	7.9e-05	0.000862	CcSEcCtD
Fluvastatin—Erythema—Methotrexate—urinary bladder cancer	7.87e-05	0.000858	CcSEcCtD
Fluvastatin—Headache—Gemcitabine—urinary bladder cancer	7.87e-05	0.000858	CcSEcCtD
Fluvastatin—Flushing—Epirubicin—urinary bladder cancer	7.86e-05	0.000856	CcSEcCtD
Fluvastatin—Cardiac disorder—Epirubicin—urinary bladder cancer	7.86e-05	0.000856	CcSEcCtD
Fluvastatin—Vomiting—Fluorouracil—urinary bladder cancer	7.85e-05	0.000856	CcSEcCtD
Fluvastatin—Rhinitis—Doxorubicin—urinary bladder cancer	7.85e-05	0.000856	CcSEcCtD
Fluvastatin—Hepatitis—Doxorubicin—urinary bladder cancer	7.83e-05	0.000854	CcSEcCtD
Fluvastatin—Hypoaesthesia—Doxorubicin—urinary bladder cancer	7.79e-05	0.000849	CcSEcCtD
Fluvastatin—Rash—Fluorouracil—urinary bladder cancer	7.79e-05	0.000849	CcSEcCtD
Fluvastatin—Dermatitis—Fluorouracil—urinary bladder cancer	7.78e-05	0.000848	CcSEcCtD
Fluvastatin—Pharyngitis—Doxorubicin—urinary bladder cancer	7.77e-05	0.000847	CcSEcCtD
Fluvastatin—Headache—Fluorouracil—urinary bladder cancer	7.74e-05	0.000843	CcSEcCtD
Fluvastatin—Oedema peripheral—Doxorubicin—urinary bladder cancer	7.72e-05	0.000841	CcSEcCtD
Fluvastatin—Dysgeusia—Methotrexate—urinary bladder cancer	7.71e-05	0.00084	CcSEcCtD
Fluvastatin—Asthenia—Etoposide—urinary bladder cancer	7.7e-05	0.000839	CcSEcCtD
Fluvastatin—Connective tissue disorder—Doxorubicin—urinary bladder cancer	7.7e-05	0.000839	CcSEcCtD
Fluvastatin—Angiopathy—Epirubicin—urinary bladder cancer	7.68e-05	0.000837	CcSEcCtD
Fluvastatin—Immune system disorder—Epirubicin—urinary bladder cancer	7.65e-05	0.000833	CcSEcCtD
Fluvastatin—Back pain—Methotrexate—urinary bladder cancer	7.62e-05	0.00083	CcSEcCtD
Fluvastatin—Chills—Epirubicin—urinary bladder cancer	7.6e-05	0.000828	CcSEcCtD
Fluvastatin—Pruritus—Etoposide—urinary bladder cancer	7.59e-05	0.000827	CcSEcCtD
Fluvastatin—Arrhythmia—Epirubicin—urinary bladder cancer	7.56e-05	0.000824	CcSEcCtD
Fluvastatin—Visual impairment—Doxorubicin—urinary bladder cancer	7.55e-05	0.000823	CcSEcCtD
Fluvastatin—Alopecia—Epirubicin—urinary bladder cancer	7.48e-05	0.000815	CcSEcCtD
Fluvastatin—Nausea—Gemcitabine—urinary bladder cancer	7.46e-05	0.000813	CcSEcCtD
Fluvastatin—Vomiting—Cisplatin—urinary bladder cancer	7.45e-05	0.000812	CcSEcCtD
Fluvastatin—Mental disorder—Epirubicin—urinary bladder cancer	7.42e-05	0.000808	CcSEcCtD
Fluvastatin—Erythema multiforme—Doxorubicin—urinary bladder cancer	7.41e-05	0.000807	CcSEcCtD
Fluvastatin—Rash—Cisplatin—urinary bladder cancer	7.38e-05	0.000805	CcSEcCtD
Fluvastatin—Dermatitis—Cisplatin—urinary bladder cancer	7.38e-05	0.000804	CcSEcCtD
Fluvastatin—Erythema—Epirubicin—urinary bladder cancer	7.37e-05	0.000803	CcSEcCtD
Fluvastatin—Diarrhoea—Etoposide—urinary bladder cancer	7.34e-05	0.0008	CcSEcCtD
Fluvastatin—Nausea—Fluorouracil—urinary bladder cancer	7.34e-05	0.0008	CcSEcCtD
Fluvastatin—Ill-defined disorder—Methotrexate—urinary bladder cancer	7.31e-05	0.000796	CcSEcCtD
Fluvastatin—Flushing—Doxorubicin—urinary bladder cancer	7.27e-05	0.000792	CcSEcCtD
Fluvastatin—Cardiac disorder—Doxorubicin—urinary bladder cancer	7.27e-05	0.000792	CcSEcCtD
Fluvastatin—Flatulence—Epirubicin—urinary bladder cancer	7.26e-05	0.000791	CcSEcCtD
Fluvastatin—Dysgeusia—Epirubicin—urinary bladder cancer	7.22e-05	0.000786	CcSEcCtD
Fluvastatin—Back pain—Epirubicin—urinary bladder cancer	7.13e-05	0.000777	CcSEcCtD
Fluvastatin—Angiopathy—Doxorubicin—urinary bladder cancer	7.11e-05	0.000775	CcSEcCtD
Fluvastatin—Malaise—Methotrexate—urinary bladder cancer	7.1e-05	0.000774	CcSEcCtD
Fluvastatin—Dizziness—Etoposide—urinary bladder cancer	7.09e-05	0.000773	CcSEcCtD
Fluvastatin—Muscle spasms—Epirubicin—urinary bladder cancer	7.08e-05	0.000772	CcSEcCtD
Fluvastatin—Immune system disorder—Doxorubicin—urinary bladder cancer	7.07e-05	0.000771	CcSEcCtD
Fluvastatin—Vertigo—Methotrexate—urinary bladder cancer	7.07e-05	0.000771	CcSEcCtD
Fluvastatin—Leukopenia—Methotrexate—urinary bladder cancer	7.05e-05	0.000768	CcSEcCtD
Fluvastatin—Chills—Doxorubicin—urinary bladder cancer	7.03e-05	0.000766	CcSEcCtD
Fluvastatin—Arrhythmia—Doxorubicin—urinary bladder cancer	7e-05	0.000763	CcSEcCtD
Fluvastatin—Nausea—Cisplatin—urinary bladder cancer	6.96e-05	0.000758	CcSEcCtD
Fluvastatin—Alopecia—Doxorubicin—urinary bladder cancer	6.92e-05	0.000754	CcSEcCtD
Fluvastatin—Cough—Methotrexate—urinary bladder cancer	6.87e-05	0.000749	CcSEcCtD
Fluvastatin—Mental disorder—Doxorubicin—urinary bladder cancer	6.86e-05	0.000748	CcSEcCtD
Fluvastatin—Ill-defined disorder—Epirubicin—urinary bladder cancer	6.84e-05	0.000745	CcSEcCtD
Fluvastatin—Vomiting—Etoposide—urinary bladder cancer	6.82e-05	0.000743	CcSEcCtD
Fluvastatin—Erythema—Doxorubicin—urinary bladder cancer	6.82e-05	0.000743	CcSEcCtD
Fluvastatin—Rash—Etoposide—urinary bladder cancer	6.76e-05	0.000737	CcSEcCtD
Fluvastatin—Dermatitis—Etoposide—urinary bladder cancer	6.76e-05	0.000737	CcSEcCtD
Fluvastatin—Headache—Etoposide—urinary bladder cancer	6.72e-05	0.000733	CcSEcCtD
Fluvastatin—Flatulence—Doxorubicin—urinary bladder cancer	6.72e-05	0.000732	CcSEcCtD
Fluvastatin—Myalgia—Methotrexate—urinary bladder cancer	6.7e-05	0.000731	CcSEcCtD
Fluvastatin—Chest pain—Methotrexate—urinary bladder cancer	6.7e-05	0.000731	CcSEcCtD
Fluvastatin—Arthralgia—Methotrexate—urinary bladder cancer	6.7e-05	0.000731	CcSEcCtD
Fluvastatin—Dysgeusia—Doxorubicin—urinary bladder cancer	6.68e-05	0.000728	CcSEcCtD
Fluvastatin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	6.66e-05	0.000726	CcSEcCtD
Fluvastatin—Malaise—Epirubicin—urinary bladder cancer	6.65e-05	0.000724	CcSEcCtD
Fluvastatin—Discomfort—Methotrexate—urinary bladder cancer	6.62e-05	0.000722	CcSEcCtD
Fluvastatin—Vertigo—Epirubicin—urinary bladder cancer	6.62e-05	0.000722	CcSEcCtD
Fluvastatin—Syncope—Epirubicin—urinary bladder cancer	6.61e-05	0.00072	CcSEcCtD
Fluvastatin—Leukopenia—Epirubicin—urinary bladder cancer	6.6e-05	0.000719	CcSEcCtD
Fluvastatin—Back pain—Doxorubicin—urinary bladder cancer	6.6e-05	0.000719	CcSEcCtD
Fluvastatin—Muscle spasms—Doxorubicin—urinary bladder cancer	6.56e-05	0.000714	CcSEcCtD
Fluvastatin—Confusional state—Methotrexate—urinary bladder cancer	6.48e-05	0.000706	CcSEcCtD
Fluvastatin—Loss of consciousness—Epirubicin—urinary bladder cancer	6.48e-05	0.000706	CcSEcCtD
Fluvastatin—Cough—Epirubicin—urinary bladder cancer	6.43e-05	0.000701	CcSEcCtD
Fluvastatin—Anaphylactic shock—Methotrexate—urinary bladder cancer	6.43e-05	0.0007	CcSEcCtD
Fluvastatin—Infection—Methotrexate—urinary bladder cancer	6.38e-05	0.000696	CcSEcCtD
Fluvastatin—Nausea—Etoposide—urinary bladder cancer	6.37e-05	0.000695	CcSEcCtD
Fluvastatin—Hypertension—Epirubicin—urinary bladder cancer	6.36e-05	0.000693	CcSEcCtD
Fluvastatin—Ill-defined disorder—Doxorubicin—urinary bladder cancer	6.33e-05	0.000689	CcSEcCtD
Fluvastatin—Nervous system disorder—Methotrexate—urinary bladder cancer	6.3e-05	0.000687	CcSEcCtD
Fluvastatin—Thrombocytopenia—Methotrexate—urinary bladder cancer	6.29e-05	0.000686	CcSEcCtD
Fluvastatin—Chest pain—Epirubicin—urinary bladder cancer	6.27e-05	0.000684	CcSEcCtD
Fluvastatin—Myalgia—Epirubicin—urinary bladder cancer	6.27e-05	0.000684	CcSEcCtD
Fluvastatin—Arthralgia—Epirubicin—urinary bladder cancer	6.27e-05	0.000684	CcSEcCtD
Fluvastatin—Anxiety—Epirubicin—urinary bladder cancer	6.25e-05	0.000681	CcSEcCtD
Fluvastatin—Skin disorder—Methotrexate—urinary bladder cancer	6.24e-05	0.00068	CcSEcCtD
Fluvastatin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	6.23e-05	0.000679	CcSEcCtD
Fluvastatin—Hyperhidrosis—Methotrexate—urinary bladder cancer	6.21e-05	0.000677	CcSEcCtD
Fluvastatin—Discomfort—Epirubicin—urinary bladder cancer	6.2e-05	0.000676	CcSEcCtD
Fluvastatin—Malaise—Doxorubicin—urinary bladder cancer	6.15e-05	0.00067	CcSEcCtD
Fluvastatin—Vertigo—Doxorubicin—urinary bladder cancer	6.13e-05	0.000668	CcSEcCtD
Fluvastatin—Anorexia—Methotrexate—urinary bladder cancer	6.13e-05	0.000668	CcSEcCtD
Fluvastatin—Syncope—Doxorubicin—urinary bladder cancer	6.11e-05	0.000666	CcSEcCtD
Fluvastatin—Leukopenia—Doxorubicin—urinary bladder cancer	6.1e-05	0.000665	CcSEcCtD
Fluvastatin—Confusional state—Epirubicin—urinary bladder cancer	6.06e-05	0.000661	CcSEcCtD
Fluvastatin—Anaphylactic shock—Epirubicin—urinary bladder cancer	6.01e-05	0.000655	CcSEcCtD
Fluvastatin—Loss of consciousness—Doxorubicin—urinary bladder cancer	5.99e-05	0.000653	CcSEcCtD
Fluvastatin—Infection—Epirubicin—urinary bladder cancer	5.97e-05	0.000651	CcSEcCtD
Fluvastatin—Cough—Doxorubicin—urinary bladder cancer	5.95e-05	0.000648	CcSEcCtD
Fluvastatin—Shock—Epirubicin—urinary bladder cancer	5.92e-05	0.000645	CcSEcCtD
Fluvastatin—Nervous system disorder—Epirubicin—urinary bladder cancer	5.9e-05	0.000643	CcSEcCtD
Fluvastatin—Thrombocytopenia—Epirubicin—urinary bladder cancer	5.89e-05	0.000642	CcSEcCtD
Fluvastatin—Hypertension—Doxorubicin—urinary bladder cancer	5.89e-05	0.000642	CcSEcCtD
Fluvastatin—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	5.86e-05	0.000638	CcSEcCtD
Fluvastatin—Skin disorder—Epirubicin—urinary bladder cancer	5.84e-05	0.000637	CcSEcCtD
Fluvastatin—Hyperhidrosis—Epirubicin—urinary bladder cancer	5.81e-05	0.000634	CcSEcCtD
Fluvastatin—Insomnia—Methotrexate—urinary bladder cancer	5.81e-05	0.000633	CcSEcCtD
Fluvastatin—Arthralgia—Doxorubicin—urinary bladder cancer	5.8e-05	0.000633	CcSEcCtD
Fluvastatin—Myalgia—Doxorubicin—urinary bladder cancer	5.8e-05	0.000633	CcSEcCtD
Fluvastatin—Chest pain—Doxorubicin—urinary bladder cancer	5.8e-05	0.000633	CcSEcCtD
Fluvastatin—Anxiety—Doxorubicin—urinary bladder cancer	5.78e-05	0.00063	CcSEcCtD
Fluvastatin—Paraesthesia—Methotrexate—urinary bladder cancer	5.77e-05	0.000629	CcSEcCtD
Fluvastatin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	5.76e-05	0.000628	CcSEcCtD
Fluvastatin—Discomfort—Doxorubicin—urinary bladder cancer	5.74e-05	0.000625	CcSEcCtD
Fluvastatin—Anorexia—Epirubicin—urinary bladder cancer	5.73e-05	0.000625	CcSEcCtD
Fluvastatin—Dyspnoea—Methotrexate—urinary bladder cancer	5.73e-05	0.000624	CcSEcCtD
Fluvastatin—Dyspepsia—Methotrexate—urinary bladder cancer	5.66e-05	0.000617	CcSEcCtD
Fluvastatin—Confusional state—Doxorubicin—urinary bladder cancer	5.61e-05	0.000612	CcSEcCtD
Fluvastatin—Decreased appetite—Methotrexate—urinary bladder cancer	5.59e-05	0.000609	CcSEcCtD
Fluvastatin—Anaphylactic shock—Doxorubicin—urinary bladder cancer	5.56e-05	0.000606	CcSEcCtD
Fluvastatin—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	5.55e-05	0.000605	CcSEcCtD
Fluvastatin—Fatigue—Methotrexate—urinary bladder cancer	5.54e-05	0.000604	CcSEcCtD
Fluvastatin—Infection—Doxorubicin—urinary bladder cancer	5.53e-05	0.000603	CcSEcCtD
Fluvastatin—Pain—Methotrexate—urinary bladder cancer	5.5e-05	0.000599	CcSEcCtD
Fluvastatin—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	5.48e-05	0.000597	CcSEcCtD
Fluvastatin—Shock—Doxorubicin—urinary bladder cancer	5.47e-05	0.000597	CcSEcCtD
Fluvastatin—Nervous system disorder—Doxorubicin—urinary bladder cancer	5.46e-05	0.000595	CcSEcCtD
Fluvastatin—Thrombocytopenia—Doxorubicin—urinary bladder cancer	5.45e-05	0.000594	CcSEcCtD
Fluvastatin—Insomnia—Epirubicin—urinary bladder cancer	5.44e-05	0.000593	CcSEcCtD
Fluvastatin—Skin disorder—Doxorubicin—urinary bladder cancer	5.41e-05	0.000589	CcSEcCtD
Fluvastatin—Paraesthesia—Epirubicin—urinary bladder cancer	5.4e-05	0.000589	CcSEcCtD
Fluvastatin—Hyperhidrosis—Doxorubicin—urinary bladder cancer	5.38e-05	0.000586	CcSEcCtD
Fluvastatin—Dyspnoea—Epirubicin—urinary bladder cancer	5.36e-05	0.000584	CcSEcCtD
Fluvastatin—Anorexia—Doxorubicin—urinary bladder cancer	5.3e-05	0.000578	CcSEcCtD
Fluvastatin—Feeling abnormal—Methotrexate—urinary bladder cancer	5.3e-05	0.000577	CcSEcCtD
Fluvastatin—Dyspepsia—Epirubicin—urinary bladder cancer	5.29e-05	0.000577	CcSEcCtD
Fluvastatin—Gastrointestinal pain—Methotrexate—urinary bladder cancer	5.26e-05	0.000573	CcSEcCtD
Fluvastatin—Decreased appetite—Epirubicin—urinary bladder cancer	5.23e-05	0.00057	CcSEcCtD
Fluvastatin—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	5.19e-05	0.000566	CcSEcCtD
Fluvastatin—Fatigue—Epirubicin—urinary bladder cancer	5.19e-05	0.000565	CcSEcCtD
Fluvastatin—Constipation—Epirubicin—urinary bladder cancer	5.14e-05	0.000561	CcSEcCtD
Fluvastatin—Pain—Epirubicin—urinary bladder cancer	5.14e-05	0.000561	CcSEcCtD
Fluvastatin—Urticaria—Methotrexate—urinary bladder cancer	5.11e-05	0.000556	CcSEcCtD
Fluvastatin—Abdominal pain—Methotrexate—urinary bladder cancer	5.08e-05	0.000554	CcSEcCtD
Fluvastatin—Body temperature increased—Methotrexate—urinary bladder cancer	5.08e-05	0.000554	CcSEcCtD
Fluvastatin—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	5.07e-05	0.000553	CcSEcCtD
Fluvastatin—Insomnia—Doxorubicin—urinary bladder cancer	5.03e-05	0.000549	CcSEcCtD
Fluvastatin—Paraesthesia—Doxorubicin—urinary bladder cancer	5e-05	0.000545	CcSEcCtD
Fluvastatin—Dyspnoea—Doxorubicin—urinary bladder cancer	4.96e-05	0.000541	CcSEcCtD
Fluvastatin—Feeling abnormal—Epirubicin—urinary bladder cancer	4.96e-05	0.00054	CcSEcCtD
Fluvastatin—Gastrointestinal pain—Epirubicin—urinary bladder cancer	4.92e-05	0.000536	CcSEcCtD
Fluvastatin—Dyspepsia—Doxorubicin—urinary bladder cancer	4.9e-05	0.000534	CcSEcCtD
Fluvastatin—Decreased appetite—Doxorubicin—urinary bladder cancer	4.84e-05	0.000527	CcSEcCtD
Fluvastatin—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	4.8e-05	0.000524	CcSEcCtD
Fluvastatin—Fatigue—Doxorubicin—urinary bladder cancer	4.8e-05	0.000523	CcSEcCtD
Fluvastatin—Urticaria—Epirubicin—urinary bladder cancer	4.78e-05	0.000521	CcSEcCtD
Fluvastatin—Pain—Doxorubicin—urinary bladder cancer	4.76e-05	0.000519	CcSEcCtD
Fluvastatin—Constipation—Doxorubicin—urinary bladder cancer	4.76e-05	0.000519	CcSEcCtD
Fluvastatin—Abdominal pain—Epirubicin—urinary bladder cancer	4.75e-05	0.000518	CcSEcCtD
Fluvastatin—Body temperature increased—Epirubicin—urinary bladder cancer	4.75e-05	0.000518	CcSEcCtD
Fluvastatin—Hypersensitivity—Methotrexate—urinary bladder cancer	4.73e-05	0.000516	CcSEcCtD
Fluvastatin—Asthenia—Methotrexate—urinary bladder cancer	4.61e-05	0.000503	CcSEcCtD
Fluvastatin—Feeling abnormal—Doxorubicin—urinary bladder cancer	4.59e-05	0.0005	CcSEcCtD
Fluvastatin—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	4.55e-05	0.000496	CcSEcCtD
Fluvastatin—Pruritus—Methotrexate—urinary bladder cancer	4.55e-05	0.000496	CcSEcCtD
Fluvastatin—Hypersensitivity—Epirubicin—urinary bladder cancer	4.43e-05	0.000483	CcSEcCtD
Fluvastatin—Urticaria—Doxorubicin—urinary bladder cancer	4.42e-05	0.000482	CcSEcCtD
Fluvastatin—Abdominal pain—Doxorubicin—urinary bladder cancer	4.4e-05	0.000479	CcSEcCtD
Fluvastatin—Body temperature increased—Doxorubicin—urinary bladder cancer	4.4e-05	0.000479	CcSEcCtD
Fluvastatin—Diarrhoea—Methotrexate—urinary bladder cancer	4.4e-05	0.000479	CcSEcCtD
Fluvastatin—Asthenia—Epirubicin—urinary bladder cancer	4.32e-05	0.00047	CcSEcCtD
Fluvastatin—Pruritus—Epirubicin—urinary bladder cancer	4.26e-05	0.000464	CcSEcCtD
Fluvastatin—Dizziness—Methotrexate—urinary bladder cancer	4.25e-05	0.000463	CcSEcCtD
Fluvastatin—Diarrhoea—Epirubicin—urinary bladder cancer	4.11e-05	0.000448	CcSEcCtD
Fluvastatin—Hypersensitivity—Doxorubicin—urinary bladder cancer	4.1e-05	0.000447	CcSEcCtD
Fluvastatin—Vomiting—Methotrexate—urinary bladder cancer	4.09e-05	0.000445	CcSEcCtD
Fluvastatin—Rash—Methotrexate—urinary bladder cancer	4.05e-05	0.000442	CcSEcCtD
Fluvastatin—Dermatitis—Methotrexate—urinary bladder cancer	4.05e-05	0.000441	CcSEcCtD
Fluvastatin—Headache—Methotrexate—urinary bladder cancer	4.03e-05	0.000439	CcSEcCtD
Fluvastatin—Asthenia—Doxorubicin—urinary bladder cancer	3.99e-05	0.000435	CcSEcCtD
Fluvastatin—Dizziness—Epirubicin—urinary bladder cancer	3.98e-05	0.000433	CcSEcCtD
Fluvastatin—Pruritus—Doxorubicin—urinary bladder cancer	3.94e-05	0.000429	CcSEcCtD
Fluvastatin—Vomiting—Epirubicin—urinary bladder cancer	3.82e-05	0.000417	CcSEcCtD
Fluvastatin—Nausea—Methotrexate—urinary bladder cancer	3.82e-05	0.000416	CcSEcCtD
Fluvastatin—Diarrhoea—Doxorubicin—urinary bladder cancer	3.81e-05	0.000415	CcSEcCtD
Fluvastatin—Rash—Epirubicin—urinary bladder cancer	3.79e-05	0.000413	CcSEcCtD
Fluvastatin—Dermatitis—Epirubicin—urinary bladder cancer	3.79e-05	0.000413	CcSEcCtD
Fluvastatin—Headache—Epirubicin—urinary bladder cancer	3.77e-05	0.000411	CcSEcCtD
Fluvastatin—Dizziness—Doxorubicin—urinary bladder cancer	3.68e-05	0.000401	CcSEcCtD
Fluvastatin—Nausea—Epirubicin—urinary bladder cancer	3.57e-05	0.000389	CcSEcCtD
Fluvastatin—Vomiting—Doxorubicin—urinary bladder cancer	3.54e-05	0.000386	CcSEcCtD
Fluvastatin—Rash—Doxorubicin—urinary bladder cancer	3.51e-05	0.000382	CcSEcCtD
Fluvastatin—Dermatitis—Doxorubicin—urinary bladder cancer	3.51e-05	0.000382	CcSEcCtD
Fluvastatin—Headache—Doxorubicin—urinary bladder cancer	3.49e-05	0.00038	CcSEcCtD
Fluvastatin—Nausea—Doxorubicin—urinary bladder cancer	3.31e-05	0.00036	CcSEcCtD
Fluvastatin—CYP1A2—Metabolism—CYP4B1—urinary bladder cancer	1.02e-05	0.000124	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	1.01e-05	0.000123	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—GSTP1—urinary bladder cancer	9.97e-06	0.000122	CbGpPWpGaD
Fluvastatin—UGT2B7—Metabolism—MTHFR—urinary bladder cancer	9.97e-06	0.000121	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—RRM2—urinary bladder cancer	9.96e-06	0.000121	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—NAT2—urinary bladder cancer	9.77e-06	0.000119	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—RRM2—urinary bladder cancer	9.74e-06	0.000119	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	9.67e-06	0.000118	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—SLC19A1—urinary bladder cancer	9.65e-06	0.000118	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—TYMP—urinary bladder cancer	9.64e-06	0.000118	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	9.57e-06	0.000117	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—NAT1—urinary bladder cancer	9.57e-06	0.000117	CbGpPWpGaD
Fluvastatin—UGT1A3—Metabolism—PPARG—urinary bladder cancer	9.51e-06	0.000116	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—PRSS3—urinary bladder cancer	9.4e-06	0.000115	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—TYMS—urinary bladder cancer	9.27e-06	0.000113	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	9.27e-06	0.000113	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	9.26e-06	0.000113	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—ENO2—urinary bladder cancer	9.23e-06	0.000112	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—HPGDS—urinary bladder cancer	9.23e-06	0.000112	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—RRM2—urinary bladder cancer	9.2e-06	0.000112	CbGpPWpGaD
Fluvastatin—HMGCR—Metabolism—PTGS2—urinary bladder cancer	9.17e-06	0.000112	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—GSTM1—urinary bladder cancer	9.17e-06	0.000112	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—NCOR1—urinary bladder cancer	9.17e-06	0.000112	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—GSTP1—urinary bladder cancer	9.14e-06	0.000111	CbGpPWpGaD
Fluvastatin—UGT1A3—Metabolism—CREBBP—urinary bladder cancer	9.13e-06	0.000111	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—ENO2—urinary bladder cancer	9.02e-06	0.00011	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—HPGDS—urinary bladder cancer	9.02e-06	0.00011	CbGpPWpGaD
Fluvastatin—SLCO1B3—Metabolism—PPARG—urinary bladder cancer	8.96e-06	0.000109	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—GSTT1—urinary bladder cancer	8.95e-06	0.000109	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—TYMP—urinary bladder cancer	8.87e-06	0.000108	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	8.84e-06	0.000108	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	8.82e-06	0.000107	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—TYMP—urinary bladder cancer	8.79e-06	0.000107	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—GPX1—urinary bladder cancer	8.78e-06	0.000107	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	8.76e-06	0.000107	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—GSTT1—urinary bladder cancer	8.75e-06	0.000107	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—NAT2—urinary bladder cancer	8.72e-06	0.000106	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—ERCC2—urinary bladder cancer	8.62e-06	0.000105	CbGpPWpGaD
Fluvastatin—SLCO1B3—Metabolism—CREBBP—urinary bladder cancer	8.61e-06	0.000105	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—HPGDS—urinary bladder cancer	8.52e-06	0.000104	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—ENO2—urinary bladder cancer	8.52e-06	0.000104	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—TYMS—urinary bladder cancer	8.5e-06	0.000104	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	8.47e-06	0.000103	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	8.45e-06	0.000103	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—RRM2—urinary bladder cancer	8.44e-06	0.000103	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—NCOR1—urinary bladder cancer	8.4e-06	0.000102	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—GSTM1—urinary bladder cancer	8.4e-06	0.000102	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—GSTT1—urinary bladder cancer	8.26e-06	0.000101	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	8.14e-06	9.92e-05	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—MTHFR—urinary bladder cancer	8.1e-06	9.87e-05	CbGpPWpGaD
Fluvastatin—UGT2B7—Metabolism—PPARG—urinary bladder cancer	8.08e-06	9.85e-05	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—GPX1—urinary bladder cancer	8.04e-06	9.8e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—NAT2—urinary bladder cancer	8.02e-06	9.78e-05	CbGpPWpGaD
Fluvastatin—HMGCR—Metabolism—PTEN—urinary bladder cancer	8e-06	9.75e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—NAT2—urinary bladder cancer	7.95e-06	9.69e-05	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—ERCC2—urinary bladder cancer	7.9e-06	9.62e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	7.88e-06	9.61e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—HPGDS—urinary bladder cancer	7.81e-06	9.52e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—ENO2—urinary bladder cancer	7.81e-06	9.52e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	7.77e-06	9.46e-05	CbGpPWpGaD
Fluvastatin—UGT2B7—Metabolism—CREBBP—urinary bladder cancer	7.77e-06	9.46e-05	CbGpPWpGaD
Fluvastatin—HMGCR—Metabolism—EP300—urinary bladder cancer	7.63e-06	9.3e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—GSTT1—urinary bladder cancer	7.58e-06	9.23e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	7.54e-06	9.18e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—RRM2—urinary bladder cancer	7.53e-06	9.17e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—TYMP—urinary bladder cancer	7.52e-06	9.16e-05	CbGpPWpGaD
Fluvastatin—UGT1A3—Metabolism—PTGS2—urinary bladder cancer	7.48e-06	9.11e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	7.46e-06	9.09e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	7.44e-06	9.07e-05	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—NQO1—urinary bladder cancer	7.44e-06	9.06e-05	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—MTHFR—urinary bladder cancer	7.42e-06	9.05e-05	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—NQO1—urinary bladder cancer	7.27e-06	8.86e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	7.26e-06	8.84e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	7.22e-06	8.8e-05	CbGpPWpGaD
Fluvastatin—SLCO1B3—Metabolism—PTGS2—urinary bladder cancer	7.05e-06	8.59e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—ENO2—urinary bladder cancer	6.97e-06	8.5e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—HPGDS—urinary bladder cancer	6.97e-06	8.5e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	6.93e-06	8.45e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—RRM2—urinary bladder cancer	6.93e-06	8.44e-05	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—NQO1—urinary bladder cancer	6.87e-06	8.37e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—RRM2—urinary bladder cancer	6.87e-06	8.37e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—NAT2—urinary bladder cancer	6.8e-06	8.28e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—GSTT1—urinary bladder cancer	6.76e-06	8.24e-05	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	6.66e-06	8.12e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	6.66e-06	8.11e-05	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—PPARG—urinary bladder cancer	6.57e-06	8e-05	CbGpPWpGaD
Fluvastatin—UGT1A3—Metabolism—PTEN—urinary bladder cancer	6.52e-06	7.95e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—HPGDS—urinary bladder cancer	6.41e-06	7.82e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—ENO2—urinary bladder cancer	6.41e-06	7.82e-05	CbGpPWpGaD
Fluvastatin—UGT2B7—Metabolism—PTGS2—urinary bladder cancer	6.36e-06	7.75e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	6.36e-06	7.75e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—ENO2—urinary bladder cancer	6.36e-06	7.75e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	6.32e-06	7.7e-05	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—CREBBP—urinary bladder cancer	6.31e-06	7.69e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—NQO1—urinary bladder cancer	6.3e-06	7.67e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—GSTT1—urinary bladder cancer	6.22e-06	7.58e-05	CbGpPWpGaD
Fluvastatin—UGT1A3—Metabolism—EP300—urinary bladder cancer	6.22e-06	7.58e-05	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—GSTP1—urinary bladder cancer	6.2e-06	7.56e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	6.17e-06	7.51e-05	CbGpPWpGaD
Fluvastatin—SLCO1B3—Metabolism—PTEN—urinary bladder cancer	6.15e-06	7.49e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	6.11e-06	7.44e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	6.07e-06	7.4e-05	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—GSTP1—urinary bladder cancer	6.06e-06	7.39e-05	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—PPARG—urinary bladder cancer	6.02e-06	7.33e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—RRM2—urinary bladder cancer	5.87e-06	7.15e-05	CbGpPWpGaD
Fluvastatin—SLCO1B3—Metabolism—EP300—urinary bladder cancer	5.86e-06	7.14e-05	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	5.81e-06	7.08e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—TYMP—urinary bladder cancer	5.8e-06	7.07e-05	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—CREBBP—urinary bladder cancer	5.78e-06	7.05e-05	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—TYMS—urinary bladder cancer	5.77e-06	7.03e-05	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—GSTP1—urinary bladder cancer	5.73e-06	6.98e-05	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—GSTM1—urinary bladder cancer	5.7e-06	6.95e-05	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—NCOR1—urinary bladder cancer	5.7e-06	6.95e-05	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—TYMS—urinary bladder cancer	5.64e-06	6.87e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—NQO1—urinary bladder cancer	5.62e-06	6.85e-05	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—GSTM1—urinary bladder cancer	5.57e-06	6.79e-05	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—NCOR1—urinary bladder cancer	5.57e-06	6.79e-05	CbGpPWpGaD
Fluvastatin—UGT2B7—Metabolism—PTEN—urinary bladder cancer	5.55e-06	6.76e-05	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	5.54e-06	6.75e-05	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—GPX1—urinary bladder cancer	5.46e-06	6.65e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	5.45e-06	6.65e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—ENO2—urinary bladder cancer	5.43e-06	6.62e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—HPGDS—urinary bladder cancer	5.43e-06	6.62e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	5.4e-06	6.58e-05	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—ERCC2—urinary bladder cancer	5.36e-06	6.53e-05	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—GPX1—urinary bladder cancer	5.34e-06	6.5e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	5.33e-06	6.49e-05	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—TYMS—urinary bladder cancer	5.33e-06	6.49e-05	CbGpPWpGaD
Fluvastatin—UGT2B7—Metabolism—EP300—urinary bladder cancer	5.29e-06	6.44e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—GSTT1—urinary bladder cancer	5.27e-06	6.42e-05	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—GSTM1—urinary bladder cancer	5.26e-06	6.41e-05	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—NCOR1—urinary bladder cancer	5.26e-06	6.41e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—GSTP1—urinary bladder cancer	5.25e-06	6.4e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—NAT2—urinary bladder cancer	5.25e-06	6.39e-05	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—ERCC2—urinary bladder cancer	5.24e-06	6.38e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	5.19e-06	6.32e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—NQO1—urinary bladder cancer	5.17e-06	6.3e-05	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—PTGS2—urinary bladder cancer	5.17e-06	6.3e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—NQO1—urinary bladder cancer	5.13e-06	6.24e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	5.08e-06	6.19e-05	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—GPX1—urinary bladder cancer	5.04e-06	6.14e-05	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—MTHFR—urinary bladder cancer	5.04e-06	6.14e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	4.97e-06	6.06e-05	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—ERCC2—urinary bladder cancer	4.95e-06	6.03e-05	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—MTHFR—urinary bladder cancer	4.92e-06	6e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—TYMS—urinary bladder cancer	4.88e-06	5.95e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—GSTM1—urinary bladder cancer	4.83e-06	5.88e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—NCOR1—urinary bladder cancer	4.83e-06	5.88e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	4.76e-06	5.8e-05	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—PTGS2—urinary bladder cancer	4.74e-06	5.77e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—GSTP1—urinary bladder cancer	4.69e-06	5.71e-05	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—MTHFR—urinary bladder cancer	4.65e-06	5.67e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—GPX1—urinary bladder cancer	4.62e-06	5.63e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—ERCC2—urinary bladder cancer	4.54e-06	5.53e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	4.54e-06	5.53e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—RRM2—urinary bladder cancer	4.53e-06	5.52e-05	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—PTEN—urinary bladder cancer	4.51e-06	5.49e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—NQO1—urinary bladder cancer	4.38e-06	5.34e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—TYMS—urinary bladder cancer	4.36e-06	5.31e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	4.34e-06	5.28e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—GSTP1—urinary bladder cancer	4.31e-06	5.25e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—NCOR1—urinary bladder cancer	4.31e-06	5.25e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—GSTM1—urinary bladder cancer	4.31e-06	5.25e-05	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—EP300—urinary bladder cancer	4.3e-06	5.24e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	4.27e-06	5.21e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—MTHFR—urinary bladder cancer	4.27e-06	5.2e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	4.25e-06	5.18e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	4.19e-06	5.11e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—ENO2—urinary bladder cancer	4.19e-06	5.11e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	4.14e-06	5.04e-05	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—PTEN—urinary bladder cancer	4.13e-06	5.03e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—GPX1—urinary bladder cancer	4.13e-06	5.03e-05	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—PPARG—urinary bladder cancer	4.09e-06	4.98e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	4.07e-06	4.96e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—ERCC2—urinary bladder cancer	4.05e-06	4.94e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—TYMS—urinary bladder cancer	4.01e-06	4.88e-05	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—PPARG—urinary bladder cancer	3.99e-06	4.87e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—TYMS—urinary bladder cancer	3.97e-06	4.84e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	3.96e-06	4.83e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	3.96e-06	4.83e-05	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—EP300—urinary bladder cancer	3.94e-06	4.8e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	3.93e-06	4.79e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	3.93e-06	4.79e-05	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—CREBBP—urinary bladder cancer	3.92e-06	4.78e-05	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—CREBBP—urinary bladder cancer	3.84e-06	4.67e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—MTHFR—urinary bladder cancer	3.81e-06	4.64e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—GPX1—urinary bladder cancer	3.79e-06	4.62e-05	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—PPARG—urinary bladder cancer	3.77e-06	4.6e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—GPX1—urinary bladder cancer	3.76e-06	4.58e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	3.73e-06	4.54e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	3.71e-06	4.52e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	3.69e-06	4.5e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—GSTP1—urinary bladder cancer	3.65e-06	4.45e-05	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—CREBBP—urinary bladder cancer	3.62e-06	4.42e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	3.53e-06	4.31e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	3.5e-06	4.27e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	3.47e-06	4.23e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—PPARG—urinary bladder cancer	3.46e-06	4.21e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—TYMS—urinary bladder cancer	3.4e-06	4.14e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—NQO1—urinary bladder cancer	3.38e-06	4.12e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—NCOR1—urinary bladder cancer	3.36e-06	4.09e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—GSTM1—urinary bladder cancer	3.36e-06	4.09e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—CREBBP—urinary bladder cancer	3.32e-06	4.05e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—GPX1—urinary bladder cancer	3.21e-06	3.92e-05	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—PTGS2—urinary bladder cancer	3.21e-06	3.92e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—ERCC2—urinary bladder cancer	3.16e-06	3.85e-05	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—PTGS2—urinary bladder cancer	3.14e-06	3.83e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—PPARG—urinary bladder cancer	3.09e-06	3.76e-05	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—PTGS2—urinary bladder cancer	2.97e-06	3.62e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—MTHFR—urinary bladder cancer	2.97e-06	3.61e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—CREBBP—urinary bladder cancer	2.97e-06	3.61e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—PPARG—urinary bladder cancer	2.84e-06	3.46e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	2.82e-06	3.44e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—PPARG—urinary bladder cancer	2.82e-06	3.43e-05	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—PTEN—urinary bladder cancer	2.8e-06	3.42e-05	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—PTEN—urinary bladder cancer	2.74e-06	3.34e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	2.73e-06	3.32e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—PTGS2—urinary bladder cancer	2.72e-06	3.32e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	2.7e-06	3.3e-05	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—EP300—urinary bladder cancer	2.67e-06	3.26e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—TYMS—urinary bladder cancer	2.62e-06	3.19e-05	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—EP300—urinary bladder cancer	2.61e-06	3.18e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	2.59e-06	3.16e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	2.59e-06	3.16e-05	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—PTEN—urinary bladder cancer	2.59e-06	3.15e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—GPX1—urinary bladder cancer	2.48e-06	3.02e-05	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—EP300—urinary bladder cancer	2.47e-06	3.01e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	2.44e-06	2.97e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—PTGS2—urinary bladder cancer	2.43e-06	2.96e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—PPARG—urinary bladder cancer	2.41e-06	2.93e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—PTEN—urinary bladder cancer	2.37e-06	2.89e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—CREBBP—urinary bladder cancer	2.31e-06	2.82e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	2.29e-06	2.79e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—EP300—urinary bladder cancer	2.26e-06	2.76e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	2.23e-06	2.72e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	2.21e-06	2.7e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—PTEN—urinary bladder cancer	2.12e-06	2.58e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—EP300—urinary bladder cancer	2.02e-06	2.46e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—PTEN—urinary bladder cancer	1.95e-06	2.37e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—PTEN—urinary bladder cancer	1.93e-06	2.35e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—PTGS2—urinary bladder cancer	1.89e-06	2.31e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—EP300—urinary bladder cancer	1.86e-06	2.26e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—PPARG—urinary bladder cancer	1.86e-06	2.26e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—EP300—urinary bladder cancer	1.84e-06	2.24e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	1.78e-06	2.17e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—PTEN—urinary bladder cancer	1.65e-06	2.01e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—EP300—urinary bladder cancer	1.57e-06	1.92e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	1.46e-06	1.78e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—PTEN—urinary bladder cancer	1.27e-06	1.55e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—EP300—urinary bladder cancer	1.21e-06	1.48e-05	CbGpPWpGaD
